Skip to main content

Advertisement

SpringerLink
Log in

Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

Proteus mirabilis is responsible for a wide range of infections that affect the urinary tract, the respiratory tract, burns, wounds and the feet of individuals with diabetes. They are highly resistant to antimicrobial agents, and new therapeutic options are therefore needed to combat this pathogen. The use of bacteriophages is one option that may be useful in treating multidrug-resistant (MDR) Proteus mirabilis infections, especially biofilm-based infections. The aim of this study was to control biofilms formed by MDR Proteus mirabilis using bacteriophages. Proteus mirabilis isolates were identified based on biochemical tests, and their resistance profiles were determined by the disk diffusion method. The biofilm-forming capacity of the isolates was assessed by the spectrophotometric method. Bacteriophages attacking Proteus mirabilis were isolated from sewage. The effect of phage on biofilm formation was investigated by the viable count method. A high rate of drug resistance was found (87.2%). Strong biofilm formation was observed in 80.5% of isolates, while moderate production was found in 19.5%. Five bacteriophages were isolated from sewage and were tested for their ability to eliminate biofilms. Significant disruption of pre-formed biofilms was observed that reached up to 99.9% decrease in the number of viable cells. The use of bacteriophages is considered a promising strategy against the biofilm infections caused by MDR Proteus mirabilis isolates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Abbas HA, Gad AI (2014) Eradication of biofilms formed by bacteria isolated from diabetic foot infections by potential antibiofilm agents alone and in combination with ciprofloxacin. Afr J Microbiol Res 8:3882–3892

    Google Scholar 

  2. Abbas HA, El-Saysed MA, Ganiny AM, Fattah AA (2018) Antimicrobial resistance patterns of Proteus mirabilis isolates from urinary tract, burn wound and diabetic foot infections. Res J Pharm Tech 11:249–252

    Article  Google Scholar 

  3. Adeolu M, Alnajar S, Naushad S, Gupta RS (2016) Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int J Syst Evol Microbiol 66:5575–5599

    Article  CAS  PubMed  Google Scholar 

  4. Afriani R, Rusmana I, Budiarti S (2014) Characterization of Proteus mirabilis lytic phage from Situ Letik River Bogor Indonesia. Int J Innovat Res Sci Eng 2:2347–3207

    Google Scholar 

  5. Akova M (2016) Epidemiology of antimicrobial resistance in bloodstream infections. Virulence 7:252–266

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Azeredo J, Sutherland IW (2008) The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 9:261–266

    Article  CAS  PubMed  Google Scholar 

  7. Carey-Smith GV, Billington C, Cornelius AJ, Hudson JA, Heinemann JA (2006) Isolation and characterization of bacteriophages infecting Salmonella spp. FEMS Microbiol Lett 258:182–186

    Article  CAS  PubMed  Google Scholar 

  8. Carlton RM (1999) Phage therapy: past history and future prospects. Arch Immunol Ther Exp (Warsz) 47:267–274

    CAS  Google Scholar 

  9. Carson L, Gorman SP, Gilmore BF (2010) The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol Med Microbiol 59:447–455

    Article  CAS  PubMed  Google Scholar 

  10. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A (1999) The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771–1776

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Cerveny KE, DePaola A, Duckworth DH, Gulig PA (2002) Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect Immun 70:6251–6262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chan BK, Abedon ST, Loc-Carrillo C (2013) Phage cocktails and the future of phage therapy. Fut Microbiol 8:769–783

    Article  CAS  Google Scholar 

  13. Chen C-Y, Chen Y-H, Lu P-L, Lin W-R, Chen T-C, Lin C-Y (2012) Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes. J Microbiol Immunol Infect 45:228–236

    Article  CAS  PubMed  Google Scholar 

  14. Clark JR, March JB (2006) Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol 24:212–218

    Article  CAS  PubMed  Google Scholar 

  15. CLSI-Clinical and Laboratory Standards Institute (2016) Performance standards for antimicrobial susceptibility testing, CLSI document M100-S-26. CLSI-Clinical and Laboratory Standards Institute, Wayne

    Google Scholar 

  16. Coker C, Poore CA, Li X, Mobley HL (2000) Pathogenesis of Proteus mirabilis urinary tract infection. Microb Infect 2:1497–1505

    Article  CAS  Google Scholar 

  17. Cornelissen A, Ceyssens P-J, T’syen J, Van Praet H, Noben J-P, Shaburova OV, Krylov VN, Volckaert G, Lavigne R (2011) The T7-related Pseudomonas putida phage φ15 displays virionassociated biofilm degradation properties. PLoS One 6:e18597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Danis-Wlodarczyk K, Olszak T, Arabski M, Wasik S, Majkowska-Skrobek G, Augustyniak D, Gula G, Briers Y, Jang HB, Vandenheuvel D, Duda KA, Lavigne R, Drulis-Kawa Z (2015) Characterization of the newly isolated lytic bacteriophages KTN6 and KT28 and their efficacy against Pseudomonas aeruginosa biofilm. PLoS One 10:e0127603

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Endimiani A, Luzzaro F, Brigante G, Perilli M, Lombardi G, Amicosante G, Rossolini GM, Toniolo A (2005) Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases. Antimicrob Agents Chemother 49:2598–2605

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Fard RMN, Barton MD, Heuzenroeder MW (2010) Novel Bacteriophages in Enterococcus spp. Curr Microbiol 60:400–406

    Article  CAS  Google Scholar 

  21. Ghannad MS, Mohammadi A (2012) Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria. Iran J Basic Med Sci 15:693–701

    CAS  Google Scholar 

  22. Goodridge LD (2010) Designing phage therapeutics. Curr Pharm Biotechnol 11:15–27

    Article  CAS  PubMed  Google Scholar 

  23. Gurnev PA, Oppenheim AB, Winterhalter M, Bezrukov SM (2006) Docking of a single phage lambda to its membrane receptor maltoporin as a time-resolved event. J Mol Biol 359:1447–1455

    Article  CAS  PubMed  Google Scholar 

  24. Gutiérrez D, Vandenheuvel D, Martínez B, Rodríguez A, Lavigne R, García P (2015) Two phages, phiIPLA-RODI and phiIPLA-C1C, lyse mono-and dual-species Staphylococcal biofilms. Appl Environ Microbiol 81:3336–3348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108

    Article  CAS  PubMed  Google Scholar 

  26. Hall-Stoodley L, Stoodley P (2009) Evolving concepts in biofilm infections. Cell Microbiol 11:1034–1043

    Article  CAS  PubMed  Google Scholar 

  27. Harper D, Enright M (2011) Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J Appl Microbiol 111:1–7

    Article  CAS  PubMed  Google Scholar 

  28. Harrison JJ, Turner RJ, Joo DA, Stan MA, Chan CS, Allan ND, Vrionis HA, Olson ME, Ceri H (2008) Copper and quaternary ammonium cations exert synergistic bactericidal and anti-biofilm activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 52:2870–2881

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ho K (2001) Bacteriophage therapy for bacterial infections. Rekindling a memory from the pre-antibiotics era. Perspect Biol Med 44:1–16

    Article  CAS  PubMed  Google Scholar 

  30. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35:322–332

    Article  CAS  PubMed  Google Scholar 

  31. Jacobsen SM, Shirtliff ME (2011) Proteus mirabilis biofilms and catheter-associated urinary tract infections. Virulence 2:460–465

    Article  PubMed  Google Scholar 

  32. Jun JW, Kim JH, Shin SP, Han JE, Chai JY, Park SC (2013) Characterization and complete genome sequence of the Shigella bacteriophage pSf-1. Res Microbiol 164:979–986

    Article  CAS  PubMed  Google Scholar 

  33. Karaca B, Akcelik N, Akcelik M (2015) Effects of P22 bacteriophage on Salmonella enterica subsp. enterica serovar Typhimurium DMC4 strain biofilm formation and eradication. Arch Biol Sci 67:1361–1367

    Article  Google Scholar 

  34. Karumidze N, Kusradze I, Rigvava S, Goderdzishvili M, Rajakumar K, Alavidze Z (2013) Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca. Curr Microbiol 66:251–258

    Article  CAS  PubMed  Google Scholar 

  35. Koneman E, Winn WC, Allen S, Janda W, Procop G, Schreckenberger P, Woods G (2006) Koneman’s color atlas and textbook of diagnostic microbiology, 6th edn. Lippincott Williams & Wilkins, Pennsylvania

    Google Scholar 

  36. Koskella B, Meaden S (2013) Understanding bacteriophage specificity in natural microbial communities. Viruses 5:806–823

    Article  PubMed  PubMed Central  Google Scholar 

  37. Krylov VN (2001) Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations. Genetika 37:869–887

    CAS  PubMed  Google Scholar 

  38. Kutateladze M, Adamia R (2010) Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 28:591–595

    Article  CAS  PubMed  Google Scholar 

  39. Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11:69–86

    Article  CAS  PubMed  Google Scholar 

  40. Labrie SJ, Samson JE, Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317–327

    Article  CAS  PubMed  Google Scholar 

  41. Lehman SM, Donlan RM (2015) Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model. Antimicrob Agents Chemother 59:1127–1137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45:999–1007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Lewis K (2010) Persister cells. Annu Rev Microbiol 64:357–372

    Article  CAS  PubMed  Google Scholar 

  44. Liu M, Deora R, Doulatov SR, Gingery M, Eiserling FA, Preston A, Maskell DJ, Simons RW, Cotter PA, Parkhill J, Miller JF (2002) Reverse transcriptase-mediated tropism switching in Bordetella bacteriophage. Science 295:2091–2094

    Article  CAS  PubMed  Google Scholar 

  45. Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1:111–114

    Article  PubMed  PubMed Central  Google Scholar 

  46. Lynch AS, Robertson GT (2008) Bacterial and fungal biofilm infections. Annu Rev Med 59:415–428

    Article  CAS  PubMed  Google Scholar 

  47. Melo LD, Veiga P, Cerca N, Kropinski AM, Almeida C, Azeredo J, Sillankorva S (2016) Development of a phage cocktail to control Proteus mirabilis catheter-associated urinary tract infections. Front Microbiol 7:1024–1035

    Article  PubMed  PubMed Central  Google Scholar 

  48. Modi SR, Collins JJ, Relman DA (2014) Antibiotics and the gut microbiota. J Clin Invest 124:4212–4218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Morozova V, Kozlova Y, Shedko E, Kurilshikov A, Babkin I, Tupikin A, Yunusova A, Chernonosov A, Baykov I, Capital Kabul CI, Kabilov M, Ryabchikova E, Vlassov V, Tikunova N (2016) Lytic bacteriophage PM16 specific for Proteus mirabilis: a novel member of the genus Phikmvvirus. Arch Virol 161:2457–2472

    Article  CAS  PubMed  Google Scholar 

  50. Morozova V, Kozlova Y, Shedko E, Babkin I, Kurilshikov A, Bokovaya O, Bardashova A, Yunusova A, Tikunov A, Tupikin A, Ushakova T, Ryabchikova E, Tikunova N (2018) Isolation and characterization of a group of new Proteus bacteriophages. Arch Virol 163:2189–2197

    Article  CAS  PubMed  Google Scholar 

  51. Nzakizwanayo J, Hanin A, Alves DR, McCutcheon B, Dedi C, Salvage J, Knox K, Stewart B, Metcalfe A, Clark J (2015) Bacteriophage can prevent encrustation and blockage of urinary catheters by Proteus mirabilis. Antimicrob Agents Chemother 60:1530–1536

    Article  PubMed  Google Scholar 

  52. Parasion S, Kwiatek M, Gryko R, Mizak L, Malm A (2014) Bacteriophages as an alternative strategy for fighting biofilm development. Pol J Microbiol 63:137–145

    PubMed  Google Scholar 

  53. Perim MC, Borges Jda C, Celeste SR, Orsolin Ede F, Mendes RR, Mendes GO, Ferreira RL, Carreiro SC, Pranchevicius MC (2015) Aerobic bacterial profile and antibiotic resistance in patients with diabetic foot infections. Rev Soc Br Med Trop 48:546–554

    Article  Google Scholar 

  54. Projan S (2004) Phage-inspired antibiotics? Nat Biotechnol 22:167–168

    Article  CAS  PubMed  Google Scholar 

  55. Różalski A, Sidorczyk Z, Kotelko K (1997) Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev 61:65–89

    PubMed  PubMed Central  Google Scholar 

  56. Rydman PS, Bamford DH (2002) The lytic enzyme of bacteriophage PRD1 is associated with the viral membrane. J Bacteriol 184:104–110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Sekhar S, Vyas N, Unnikrishnan M, Rodrigues G, Mukhopadhyay C (2014) Antimicrobial susceptibility pattern in diabetic foot ulcer: a pilot study. Ann Med Health Sci Res 4:742–745

    Article  PubMed  PubMed Central  Google Scholar 

  58. Shanmugam P, Jeya M, Susan SL (2013) The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains. J Clin Diagn Res 7:441–445

    PubMed  PubMed Central  Google Scholar 

  59. Shapiro OH, Kushmaro A (2011) Bacteriophage ecology in environmental biotechnology processes. Curr Opin Biotechnol 22:449–455

    Article  CAS  PubMed  Google Scholar 

  60. Skurnik M, Strauch E (2006) Phage therapy: facts and fiction. Int J Med Microbiol 296:5–14

    Article  CAS  PubMed  Google Scholar 

  61. Stepanović S, Vuković D, Hola V, Bonaventura GD, Djukić S, Ćirković I, Ruzicka F (2007) Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. Acta Pathol Microbiol Immunol Scand B Microbiol 115:891–899

    Article  Google Scholar 

  62. Stewart PS (2002) Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292:107–113

    Article  CAS  PubMed  Google Scholar 

  63. Stickler DJ (2014) Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. J Intern Med 276:120–129

    Article  CAS  PubMed  Google Scholar 

  64. Sutherland IW, Hughes KA, Skillman LC, Tait K (2004) The interaction of phage and biofilms. FEMS Microbiol Lett 232:1–6

    Article  CAS  PubMed  Google Scholar 

  65. Thompson R (2018) The isolation and characterisation of Proteus mirabilis bacteriophages and their effect on the colonisation and blockage of urinary catheters. (PhD thesis), Faculty of Health and Applied Sciences, University of the West of England, Bristol

  66. Trachoo N (2004) Biofilm removal technique using sands as a research tool for accessing microbial attachment on surface. Songklanakarin J Sci Technol 26:109–115

    Google Scholar 

  67. Yah S, Enabulele I, Yusuf E, Eghafona N (2006) Emerging quinolones resistant transfer genes among gram-negative bacteria isolated from faeces of HIV/AIDS patient attending some clinic and hospital in the city of Benin, Edo State, Nigeria. Online J Health Allied Sci 5:61–91

    Google Scholar 

  68. Yazdi M, Bouzari M, Ghaemi EA (2018) Isolation and characterization of a lytic bacteriophage (vB_PmiS-TH) and its application in combination with ampicillin against planktonic and biofilm forms of Proteus mirabilis isolated from urinary tract infection. J Mol Microbiol Biotechnol 28:37–46

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt

    Salwa Gomaa, Fathy Serry, Hemmat Abdellatif & Hisham Abbas

Authors
  1. Salwa Gomaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fathy Serry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hemmat Abdellatif
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hisham Abbas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salwa Gomaa.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Handling Editor: T. K. Frey.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gomaa, S., Serry, F., Abdellatif, H. et al. Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages. Arch Virol 164, 2265–2275 (2019). https://doi.org/10.1007/s00705-019-04305-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-019-04305-x

Search

Navigation